Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Risks of testosterone-replacement therapy and recommendations for monitoring.

× No keyword cloud information.

114 in total

Review 1. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors: Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal: Endocr Rev Date: 2012-03-20 Impact factor: 19.871

2. Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy.

Authors: Eduard García-Cruz; Jorge Huguet; Marta Piqueras; Meritxell Pérez Márquez; Lluís Peri; Laura Izquierdo; Agustín Franco; Ricardo Alvarez-Vijande; María José Ribal; Antonio Alcaraz
Journal: World J Urol Date: 2011-08-11 Impact factor: 4.226

Review 3. Prostate cancer: Testosterone therapy for hypogonadal men with prostate cancer.

Authors: Salvatore P Catarinicchia; E David Crawford
Journal: Nat Rev Urol Date: 2016-07-19 Impact factor: 14.432

Review 4. The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.

Authors: William P Conners; Abraham Morgentaler
Journal: Curr Urol Rep Date: 2013-12 Impact factor: 3.092

5. Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010.

Authors: Jacques Baillargeon; Randall J Urban; Yong-Fang Kuo; Holly M Holmes; Mukaila A Raji; Abraham Morgentaler; Bret T Howrey; Yu-Li Lin; Kenneth J Ottenbacher
Journal: Public Health Rep Date: 2015 Mar-Apr Impact factor: 2.792

6. Testosterone replacement therapy and polycythemia in HIV-infected patients.

Authors: Charles Kyriakos Vorkas; Carlos M Vaamonde; Marshall J Glesby
Journal: AIDS Date: 2012-01-14 Impact factor: 4.177

7. Androgen insufficiency in ageing men: how is it defined and should it be treated?

Authors: Penelope Coates
Journal: Clin Biochem Rev Date: 2005-02

8. Low free and bioavailable testosterone levels may predict pathologically-proven high-risk prostate cancer: a prospective, clinical trial.

Authors: Göksel Bayar; Hakan Şirin; Mustafa Aydın; Ayşim Özağarı; Orhan Tanrıverdi; Mustafa Kadıhasanoğlu; Muammer Kendirci
Journal: Turk J Urol Date: 2017-08-01

9. Words of wisdom. Re: Testosterone treatment is a potent tumor promoter for the rat prostate.

Authors: Jason M Scovell; Peter Butler; Ranjith Ramasamy; Dolores J Lamb
Journal: Eur Urol Date: 2015-04 Impact factor: 20.096

10. Low serum testosterone increases mortality risk among male dialysis patients.

Authors: Juan Jesús Carrero; Abdul Rashid Qureshi; Paolo Parini; Stefan Arver; Bengt Lindholm; Peter Bárány; Olof Heimbürger; Peter Stenvinkel
Journal: J Am Soc Nephrol Date: 2009-01-14 Impact factor: 10.121